Intravascular hemolysis and the pathophysiology of sickle cell disease
Top Cited Papers
- 1 March 2017
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 127 (3), 750-760
- https://doi.org/10.1172/jci89741
Abstract
Hemolysis is a fundamental feature of sickle cell anemia that contributes to its pathophysiology and phenotypic variability. Decompartmentalized hemoglobin, arginase 1, asymmetric dimethylarginine, and adenine nucleotides are all products of hemolysis that promote vasomotor dysfunction, proliferative vasculopathy, and a multitude of clinical complications of pulmonary and systemic vasculopathy, including pulmonary hypertension, leg ulcers, priapism, chronic kidney disease, and large-artery ischemic stroke. Nitric oxide (NO) is inactivated by cell-free hemoglobin in a dioxygenation reaction that also oxidizes hemoglobin to methemoglobin, a non–oxygen-binding form of hemoglobin that readily loses heme. Circulating hemoglobin and heme represent erythrocytic danger-associated molecular pattern (eDAMP) molecules, which activate the innate immune system and endothelium to an inflammatory, proadhesive state that promotes sickle vaso-occlusion and acute lung injury in murine models of sickle cell disease. Intravascular hemolysis can impair NO bioavailability and cause oxidative stress, altering redox balance and amplifying physiological processes that govern blood flow, hemostasis, inflammation, and angiogenesis. These pathological responses promote regional vasoconstriction and subsequent blood vessel remodeling. Thus, intravascular hemolysis represents an intrinsic mechanism for human vascular disease that manifests clinical complications in sickle cell disease and other chronic hereditary or acquired hemolytic anemias.Keywords
This publication has 155 references indexed in Scilit:
- Therapeutic Approaches to Limit Hemolysis-Driven Endothelial Dysfunction: Scavenging Free Heme to Preserve Vasculature HomeostasisOxidative Medicine and Cellular Longevity, 2013
- Hemodynamic Characteristics and Predictors of Pulmonary Hypertension in Patients With Sickle Cell DiseaseThe American Journal of Cardiology, 2012
- Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA, 2012
- Markers of Severe Vaso-Occlusive Painful Episode Frequency in Children and Adolescents with Sickle Cell AnemiaThe Journal of Pediatrics, 2012
- TRV: A physiological biomarker in sickle cell diseasePediatric Blood & Cancer, 2011
- Laboratory and echocardiography markers in sickle cell patients with leg ulcersAmerican Journal of Hematology, 2011
- Prospective Echocardiography Assessment of Pulmonary Hypertension and Its Potential Etiologies in Children With Sickle Cell DiseaseThe American Journal of Cardiology, 2009
- Impaired nitric oxide bioavailability and l-arginine–reversible endothelial dysfunction in adults with falciparum malariaThe Journal of Experimental Medicine, 2007
- Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell diseaseAmerican Journal of Hematology, 2007
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2007